The Nearshoring Opportunity: Building a Solid Case for Oncology Studies in Canada
US Sponsors of oncology clinical trials often consider expanding their programs to Europe and Asia rather than to the nearby…
Clinical Trial Agreements no longer a bottleneck for study site activation
Ending the clinical trial agreement's sabotage of clinical trial startup Clinical trials are inherently complex, from pre-study startup through to…
‘5 step’ fail proof strategy to effective Clinical Trial Agreement Negotiations part 2
Continued from ‘5 step’ fail proof strategy to effective Clinical Trial Agreement Negotiation part 1 Nathan Currier, PhD, is Scimega's…
Oncology Clinical Operations in Canada
The nature and structure of our health care system in Canada results in patients being followed at the same center…
‘5 step’ fail proof strategy to effective Clinical Trial Agreement Negotiations part 1
Nathan Currier, PhD, is Scimega's Director of Oncology Strategy and Alliances. He brings a wealth of knowledge and excellent insight…